137 related articles for article (PubMed ID: 36461683)
1. Synthesis, antimycobacterial, cytotoxicity, anti-inflammatory, in silico studies and molecular dynamics of pyrazole-embedded thiazolidin-4-one hybrids.
Kamat V; Poojary B; Puthran D; Das VB; Kumar BK; Sankaranarayan M; Shetye G; Ma R; Franzblau SG; Nayak SP
Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200444. PubMed ID: 36461683
[TBL] [Abstract][Full Text] [Related]
2. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
Nayak N; Ramprasad J; Dalimba U
Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents.
Modi P; Patel S; Chhabria M
Bioorg Chem; 2019 Jun; 87():240-251. PubMed ID: 30908967
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Characterization, and Antimicrobial Activity Screening of Some Novel 3-(2-(3-(Substituted benzyloxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline Derivatives as Potential Antimycobacterial Agents.
Shinde A; Ugale SR; Nandurkar Y; Modak M; Chavan AP; Mhaske PC
ACS Omega; 2022 Dec; 7(50):47096-47107. PubMed ID: 36570236
[TBL] [Abstract][Full Text] [Related]
5. Pyrazole-coumarin and pyrazole-quinoline chalcones as potential antitubercular agents.
Kumar G; Siva Krishna V; Sriram D; Jachak SM
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000077. PubMed ID: 32484273
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, in silico, and in vitro evaluation of 3-phenylpyrazole acetamide derivatives as antimycobacterial agents.
Gaikwad NB; Nirmale K; Sahoo SK; Ahmad MN; Kaul G; Shukla M; Nanduri S; Das Gupta A; Chopra S; Yaddanapudi MV
Arch Pharm (Weinheim); 2021 May; 354(5):e2000349. PubMed ID: 33351199
[TBL] [Abstract][Full Text] [Related]
7. Bioevaluation of quinoline-4-carbonyl derivatives of piperazinyl-benzothiazinones as promising antimycobacterial agents.
Sahoo SK; Gajula SNR; Ahmad MN; Kaul G; Nanduri S; Sonti R; Dasgupta A; Chopra S; Yaddanapudi VM
Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200168. PubMed ID: 35876343
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
9. One-Pot Synthesis of Novel Hydrazono-1,3-Thıazolıdın-4-One Derivatives as Anti-HIV and Anti-Tubercular Agents: Synthesıs, Bıologıcal Evaluatıon, Molecular Modelling and Admet Studıes.
Pasha MA; Mondal S; Panigrahi N; Shetye G; Ma R; Franzblau SG; Zheng YT; Murugesan S
Curr HIV Res; 2022; 20(3):255-271. PubMed ID: 35549861
[TBL] [Abstract][Full Text] [Related]
10. Design of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents.
Ramprasad J; Nayak N; Dalimba U
Eur J Med Chem; 2015 Dec; 106():75-84. PubMed ID: 26520841
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of new 2-(thiazol-4-yl)thiazolidin-4-one derivatives as potential anti-mycobacterial agents.
Abhale YK; Shinde A; Shelke M; Nawale L; Sarkar D; Mhaske PC
Bioorg Chem; 2021 Oct; 115():105192. PubMed ID: 34314920
[TBL] [Abstract][Full Text] [Related]
12. Rational design and synthesis of novel diphenyl ether derivatives as antitubercular agents.
Kar SS; Bhat G V; Rao PP; Shenoy VP; Bairy I; Shenoy GG
Drug Des Devel Ther; 2016; 10():2299-310. PubMed ID: 27486307
[TBL] [Abstract][Full Text] [Related]
13. Discovery of 5-methylpyrimidopyridone analogues as selective antimycobacterial agents.
Wu Y; Cheung CY; Zhou Y; Wang Z; Tu Z; Cook GM; Lu X
Bioorg Med Chem; 2021 Nov; 49():116426. PubMed ID: 34624820
[TBL] [Abstract][Full Text] [Related]
14. Pyrazole clubbed triazolo[1,5-a]pyrimidine hybrids as an anti-tubercular agents: Synthesis, in vitro screening and molecular docking study.
Bhatt JD; Chudasama CJ; Patel KD
Bioorg Med Chem; 2015 Dec; 23(24):7711-6. PubMed ID: 26631439
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of carbohydrazides and carboxamides as anti-tubercular agents.
Kumar G; Krishna VS; Sriram D; Jachak SM
Eur J Med Chem; 2018 Aug; 156():871-884. PubMed ID: 30056283
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and antimycobacterial activity of thiazolidine-2,4-dione-based thiosemicarbazone derivatives.
Trotsko N; Golus J; Kazimierczak P; Paneth A; Przekora A; Ginalska G; Wujec M
Bioorg Chem; 2020 Apr; 97():103676. PubMed ID: 32097795
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents.
Srinivasarao S; Nandikolla A; Suresh A; Ewa AK; Głogowska A; Ghosh B; Kumar BK; Murugesan S; Pulya S; Aggarwal H; Sekhar KVGC
Bioorg Chem; 2020 Jul; 100():103955. PubMed ID: 32464405
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antimycobacterial activity of thiazolidine-2,4-dione based derivatives with halogenbenzohydrazones and pyridinecarbohydrazones substituents.
Trotsko N; Golus J; Kazimierczak P; Paneth A; Przekora A; Ginalska G; Wujec M
Eur J Med Chem; 2020 Mar; 189():112045. PubMed ID: 31951961
[TBL] [Abstract][Full Text] [Related]
20. Antitubercular properties of thiazolidin-4-ones - A review.
Trotsko N
Eur J Med Chem; 2021 Apr; 215():113266. PubMed ID: 33588179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
